Free Widgets | Feedback 
Live Share Markets - Appuonline.com


Updated:24 Jul 2017 03:31:00 PM(IST)

Investor Tool

My Stockwatch 

RELIANCE 1615.25 [ +1.91% ]TCS 2530.70 [ +1.59% ]

Sensex32245.87
216.98 0.68%

Nifty9966.40
51.15 0.52%

Midcap15226.41
40.88 0.27%

Smallcap16035.76
43.13 0.27%


Bse Corporate Announcements Back
Taro gets final approval for the Imiquimod cream Sun Pharmaceuticals Industries has 48.7% stake, and
Taro gets final approval for the Imiquimod cream Sun Pharmaceuticals Industries has 48.7% stake, and 65.8% Voting rights in Taro Pharmaceuticals. Taro Pharmaceuticals has received final approval for Abbreviated New Drug Application (ANDA) from the US Food and Drug Administration (FDA) for Imiquimod cream 5%. It was originally developed and marketed by Graceway Pharmaceuticals under the brand name cream Aldara 5%. It is indicated for the treatment of actinic Keratosis and external genital warts. It has approximate annual sales of USD 340 million in the US market. Sun Pharmaceuticals Industries has 48.7% stake, and 65.8% Voting rights in Taro Pharmaceuticals.

Market on Mobile
























Site Map  •  Mobile  •  Companies  •  Learning Centre  •  Insurance •  About  •  Contact us  •  Disclaimer
© appuonline.com